Upload
aron-wilkins
View
216
Download
1
Tags:
Embed Size (px)
Citation preview
Academic Research in the New Millennium:an EH&S Perspective
Institutional Biological and Chemical Safety Committee/
Environmental Health and SafetyJoe Kanabrocki
Biological Safety Officer747-0309
Biological & Chemical Safety
at WUSM
0200400600800
100012001400160018002000 Animal Studies
ReviewedGrant EnvironmentalApprovalsFume HoodCertificationsLab & ClinicInspectionsChemical/OdorEmergenciesRecombinant DNARegistrationsRespirator Fit Tests
Evolving Issues
•Biomedical technology.Gene “therapy”; gene transfer.Xenotransplantation.
•Emerging infectious diseases.•Bioterrorism/biowarfare threat.•Agricultural biotechnology.
Hilltop
Gene Transfer Technologies First research subject admitted to NIH Clinic for
gene therapy approx. ten years ago. Initial assumption: gene transfer to focus on
study & treatment of genetic deficiency diseases: true gene therapy. Gene transfer clinical trials to date:
Cancer (62%), monogenetic deficiency diseases (13%),AIDS (9%)
Patient dies at U. Penn.; gene trials/human studies scrutiny greatly increases.
Gene Transfer Technologies Three types of delivery vectors employed:
Viral vectors:• retroviruses• adenoviruses• adeno-associated viruses• vaccinia/fowlpox viruses• Herpes virus• Lentiviruses (HIV based vectors)
Cationic liposomes Plasmids
Infection Control for Gene Transfer Technologies
Traditional Infection Control Prevent infection. Diagnosis and therapy known. Isolation to prevent transmission.
Gene transfer Produce infection. Contain infection. Usually not treatable by conventional therapy. Isolation to prevent transmission.
Xenotransplantation Animal organs used to “bridge” human
transplant patients. Transgenic animals produced to produce
organs recognized as human (MHC genes). Presents infection control issues:
zoonoses (animal pathogens infecting humans) novel pathogens able to cross species barriers.
Emerging Diseases
Examples of new and reemerging diseases.
Emerging Diseases
Response to H5N1 avian influenza outbreak in Hong Kong.
Emerging Diseases
Benefits of emerging diseases research.
Emerging Diseases
Emerging diseases funding (National Institute of Allergy and Infectious Diseases).
Threat of Biological Terrorism and Warfare
Federal response toterror attacks
Federal agencies have requested that research institutions develop an inventory describing the nature & use of research materials associated with research activities. Centers for Disease Control and Prevention (CDC) Federal Bureau of Investigation (FBI) Department of Justice-Office of Inspector General
(DOJ-OIG)
Mandate is forthcoming (December 2002?).
Regulatory Compliance:Response to terror threats & attacks
Select Agent Transfer (SAT) Rule Rule pertains to select bacteria, viruses, fungi
and toxins with potential for use as WMD. Purpose of SAT Rule is to ensure that:
• select infectious agents & toxins shipped only to institutions/individuals equipped to handle appropriately.
• transfer of these agents is to those who have legitimate reasons to use them.
• system is implemented whereby scientists and researchers involved with legitimate research may continue transferring these agents without undue burden.
Regulatory Compliance:Response to terror threats & attacks
U.S. PATRIOT Act (Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism-2001) Extends limitations of the SAT Rule to use and
possession of Select Agents. Prohibits certain personnel from access to
select agents.• Criminal records.• Foreign nationals from certain countries.• Drug abusers.
Research ProtocolRegistration at WUStL
Why this request? What does “research protocol registration”
mean? What types of research protocols must be registered?
Who should register their research? With whom is the research registered?
How does a PI register his/her protocol? When and how often are protocols registered?
Why this request?
Federal response to terror attacks. FBI, CDC, DOJ, USDA
Regulatory compliance. NIH (recombinant DNA) OSHA (BBP and Lab Standard) DOT/FAA
The “right” thing to do. Facilitate research activities
Regulatory Compliance:Long-established requirements
National Institutes of Health: Guidelines for Research Involving
Recombinant DNA Molecules (1976). Guide for the Care and Use of Research
Animals (Occupational Health and Safety requirements for workers and investigators)
OSHA: Laboratory Standard (1990) Bloodborne Pathogens Standard (1991)
Other funding agency requirements: e.g. American Heart Association, DOD, etc.
The “Right” Thing To Do Provides basis for assessment of research
associated risks:• Primary function of Institutional Biological and
Chemical Safety Committee (IBC). Allows for determination of appropriateness
of facilities and lab work practices. Provides basis for staff training needs. Provides EH&S with info on hazardous
waste disposal needs.
The “Right” Thing To Do Provides mechanism for institutional
and PI accountability. Public outcry for accountability. St. Louis Fire Department requirements
include the establishment of inventories of research materials.
Security
Inventory of Biohazardous Materials
Inventory to be maintained in Biohazardous Materials Database.
Access database. Tracks research reagents, research
locations, personnel, training, grants supporting research, lab audit data, fume hood test data
Component of Environmental Management System (EPA initiative)
Biohazardous Materials Database
Occupational & public health info for exposure prophylaxis.
Info for support personnel(e.g. maintenance, custodial, etc.)
Info for lab decommissioning. Regulatory compliance records. Provides registry of WUStL research
resources for campus investigators.
What does “research protocol registration” mean?
Completion of a registration form describing research program elements and protocols.
Program-based research protocol description, not grant-based.
Graded approach-emphasis on risk The greater the risk, the greater the
required detail.
Who should register their research?
Investigators should register their research if:
they have Principal Investigator status; their research involves regulated or
hazardous biological agents and/or materials or select chemical agents.
With whom is theresearch registered?
Registration Program administered through the Office of Biological and Chemical Safety on behalf of the Institutional Biological and Chemical Safety Committee (IBC).
Program of the Environmental Health and Safety Department, FMD, School of Medicine.
Institutional Biological & Chemical Safety Committee
(IBC) Med School & Hilltop representation
(CHAIR: Sam Stanley, M.D.). Membership to reflect required expertise. Charge:
Review and assess risks associated with research involving etiologic agents, biological or chemical.
Review and assess risks associated with research involving recombinant DNA.
Draft IBC Policy: Research Registration
The Institutional Biological and Chemical Safety Committee (IBC) endorses registration with the
IBC of all research activities (in vitro and in vivo) involving regulated and/or potentially hazardous biological or select chemical research materials.
The bases for this endorsement include regulatory compliance documentation, inventory
assessment, security and establishment of a registry of research resources for the WUStL
research community (24 April 2002).
What types of research protocols must be registered?
Recombinant DNA molecules and recombinant DNA-containing organisms or cell cultures which are subject to the NIH Guidelines for Research Involving Recombinant DNA Molecules, including human gene therapy trials.
Pathogenic microorganisms or agents potentially infectious to humans and/or animals.
Human blood, tissues, and cell lines as well as potentially infectious animal blood, tissues and cell lines.
What types of research protocols must be registered?
Carcinogens, mutagens, teratogens, drugs, and toxins when administered in vivo to animals or in vitro to cell or tissue cultures to induce a biological outcome.
Animals for which a reasonable potential for transmission of zoonotic agents exists, e.g., wild-trapped animals, sheep, & rhesus macaques.
Exotic plants, animals or microbes (e.g., non-indigenous plant or insect pathogen, or biological control agent).
How does a PI registerhis/her protocol?
Complete Recombinant DNA and Hazardous Research Materials Protocol form.
Available at: www.ehs.wustl.edu Can be filed as e-mail attachment.
Requires printing of cover page only for signatory purposes.
When and how oftenare protocols registered?
Protocols are considered active for five years.
Amendments can be made in the interim when novel (relative to the protocol) risks or regulated materials are added to the protocol.
EH&S Initiatives IBC administrative support. Research materials and
compliance database. Web-based on-line research
registration. Coordinated compliance effort.